BioSpace News Archive

Pharm Country

Click Therapeutics Announces Participation in November Investor Conferences

Click Therapeutics, Inc., a leader in Digital Therapeutics™ as prescription medical treatments, announced that Randall Stanicky, Chief Financial Officer, will participate in the following investor conferences this month.

November 7, 2023
·
1 min read
Business

ProQR Announces Third Quarter 2023 Operating and Financial Results

ProQR Therapeutics NV. reported its financial and operating results for the third quarter ended September 30, 2023, and provided a business update.

November 7, 2023
·
15 min read
Business

Entrada Therapeutics Reports Third Quarter 2023 Financial Results

Entrada Therapeutics, Inc. reported financial results for the third quarter ending September 30, 2023, and highlighted recent business updates.

November 7, 2023
·
10 min read
Business

Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2023 Financial Results

Praxis Precision Medicines, Inc. provided a corporate update and reported financial results for the third quarter 2023.

November 7, 2023
·
9 min read
Business

Rhythm Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Update

Rhythm Pharmaceuticals, Inc. reported financial results and provided a business update for the third quarter ended September 30, 2023.

November 7, 2023
·
24 min read
Genetown

Walden Biosciences to Host Virtual Event on November 14, 2023 “Transforming the Treatment Landscape of Chronic Kidney Disease”

Walden Biosciences, Inc. announced that management will host a virtual event titled, “Transforming the Treatment Landscape of Chronic Kidney Disease,” on November 14, 2023 from 11:00 a.m. to 12:30 p.m. EST.

November 7, 2023
·
2 min read
Business

Zevra Therapeutics Reports Corporate Updates and Third Quarter 2023 Financial Results

Zevra Therapeutics, Inc., a rare disease therapeutics company, provided corporate updates and reported its financial results for the quarter ended September 30, 2023.

November 7, 2023
·
23 min read
Business

Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance

Bioventus Inc., a global leader in innovations for active healing, reported financial results for the three and nine months ended September 30, 2023.

November 7, 2023
·
34 min read
Drug Development

Milestone Pharmaceuticals to Host Investor and Analyst Webcast to Review Data from ReVeRA Phase 2 Study of Etripamil in AFib-RVR

Milestone Pharmaceuticals Inc. announced that the Company will host a virtual investor and analyst webcast on Monday, November 13, 2023 at 8:00 a.m. ET.

November 7, 2023
·
6 min read
Pharm Country

EOM Pharmaceutical Holdings Provides an Update on its Lead Drug Candidate EOM613

EOM Pharmaceutical Holdings, Inc. provides an update on its clinical program for its lead drug candidate EOM613.

November 7, 2023
·
6 min read